Combination Therapy for AMD Fails to Improve Vision Versus Single Drug



(MedPage Today) — LONG BEACH, Calif. — Outcomes in neovascular age-related macular degeneration (nAMD) failed to improve with the addition of a multitargeted trap fusion protein to anti-VEGF therapy, according to a randomized trial reported…



Source link : https://www.medpagetoday.com/meetingcoverage/asrs/116806

Author :

Publish date : 2025-08-03 00:28:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version